ArthroCare Announces Participation in Investor Conference


ArthroCare Announces Participation in Investor Conference

Misty Romines, 512-391-3902

ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

On Tuesday, November 27, 2012 ArthroCare will present during the 24 Annual Piper Jaffray Healthcare Conference. David Fitzgerald, President and Chief Executive Officer, will deliver the business presentation. Please see the conference details below.

The presentation will be webcast live and can be accessed on ArthroCare's website at . The webcast will remain available for 30 days following the presentation.

ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare’s devices use its internationally patented Coblation technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.